Every SEC Form 3/4/5 on record for this filer (CIK 1276700) — 6 issuers, 46 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PHAT | Phathom Pharmaceuticals, Inc. | Director | 2022-04-26 → 2026-05-21 | 9 | $99,125 |
| CDTX | Cidara Therapeutics, Inc. | Chief Financial Officer | 2025-02-26 → 2026-01-07 | 4 | — |
| BTTX | Better Therapeutics, Inc. | Chief Executive Officer · Director · lapsed | 2022-07-07 → 2023-12-20 | 6 | $405,726 |
| MYOV | Myovant Sciences Ltd. | Principal Fin'l & Accounting · lapsed | 2016-10-26 → 2021-07-09 | 22 | −$2M |
| ADRO | ADURO BIOTECH, INC. | Director · lapsed | 2019-04-19 → 2020-05-28 | 5 | — |
| ABUS | Arbutus Biopharma Corp | Director · lapsed | 2015-08-14 → 2017-06-23 | 3 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PHAT | 2024-12-13 | Buy | 12,500 | $7.93 | $99,125 | 57,000 |
2 of 6 issuers are covered and open a security page; the rest are on file here only.
